Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron-Emission Tomography | 10 | 2021 | 304 | 1.790 |
Why?
|
| Radiology | 4 | 2023 | 106 | 1.740 |
Why?
|
| Fluorodeoxyglucose F18 | 9 | 2021 | 147 | 1.310 |
Why?
|
| Artificial Intelligence | 6 | 2023 | 243 | 1.160 |
Why?
|
| Multimodal Imaging | 8 | 2017 | 115 | 1.100 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2017 | 3560 | 0.900 |
Why?
|
| Radiology Information Systems | 2 | 2021 | 23 | 0.890 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2021 | 79 | 0.750 |
Why?
|
| Workflow | 2 | 2021 | 118 | 0.740 |
Why?
|
| Gastroparesis | 4 | 2024 | 67 | 0.730 |
Why?
|
| Burnout, Professional | 1 | 2023 | 117 | 0.710 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2023 | 2093 | 0.700 |
Why?
|
| Radiography | 6 | 2024 | 815 | 0.640 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 171 | 0.630 |
Why?
|
| Child | 33 | 2025 | 24173 | 0.570 |
Why?
|
| Histiocytosis | 1 | 2017 | 19 | 0.560 |
Why?
|
| Ultrasonography | 5 | 2025 | 938 | 0.550 |
Why?
|
| Lung Diseases | 1 | 2021 | 383 | 0.550 |
Why?
|
| Pandemics | 4 | 2022 | 1104 | 0.530 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 291 | 0.520 |
Why?
|
| Radiopharmaceuticals | 9 | 2021 | 167 | 0.520 |
Why?
|
| Breast | 2 | 2014 | 214 | 0.500 |
Why?
|
| Hip Dislocation | 3 | 2024 | 28 | 0.470 |
Why?
|
| Whole Body Imaging | 1 | 2014 | 29 | 0.450 |
Why?
|
| Intestinal Volvulus | 2 | 2025 | 37 | 0.440 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 2509 | 0.430 |
Why?
|
| Dyspepsia | 3 | 2024 | 100 | 0.420 |
Why?
|
| Radiologists | 3 | 2022 | 45 | 0.420 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 93 | 0.410 |
Why?
|
| Lymphoma | 1 | 2016 | 321 | 0.410 |
Why?
|
| Scoliosis | 2 | 2024 | 135 | 0.390 |
Why?
|
| Humans | 49 | 2025 | 124705 | 0.380 |
Why?
|
| Foreign Bodies | 2 | 2021 | 103 | 0.340 |
Why?
|
| Gastrointestinal Diseases | 2 | 2022 | 336 | 0.290 |
Why?
|
| Gastric Emptying | 3 | 2024 | 78 | 0.280 |
Why?
|
| Digestive System Abnormalities | 2 | 2025 | 37 | 0.280 |
Why?
|
| Neuroblastoma | 2 | 2023 | 505 | 0.280 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 24 | 0.280 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 1660 | 0.260 |
Why?
|
| Adolescent | 14 | 2025 | 19221 | 0.240 |
Why?
|
| Appendicitis | 2 | 2024 | 127 | 0.220 |
Why?
|
| Female | 20 | 2025 | 66577 | 0.220 |
Why?
|
| Contrast Media | 4 | 2021 | 479 | 0.220 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 19 | 0.210 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2023 | 18 | 0.210 |
Why?
|
| Prospective Studies | 5 | 2024 | 6132 | 0.210 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2016 | 241 | 0.210 |
Why?
|
| Observer Variation | 1 | 2024 | 299 | 0.210 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 24 | 0.210 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 35 | 0.200 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 277 | 0.200 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2023 | 50 | 0.200 |
Why?
|
| Retrospective Studies | 14 | 2025 | 16263 | 0.200 |
Why?
|
| Natural Killer T-Cells | 1 | 2023 | 75 | 0.200 |
Why?
|
| Ileal Diseases | 1 | 2022 | 21 | 0.190 |
Why?
|
| Hospitals, Pediatric | 3 | 2022 | 749 | 0.190 |
Why?
|
| Ganglioneuroblastoma | 1 | 2021 | 6 | 0.190 |
Why?
|
| Ganglioneuroma | 1 | 2021 | 18 | 0.190 |
Why?
|
| Reflex | 1 | 2021 | 51 | 0.190 |
Why?
|
| Pediatrics | 2 | 2021 | 1144 | 0.180 |
Why?
|
| Intussusception | 1 | 2022 | 47 | 0.180 |
Why?
|
| Kidney Neoplasms | 2 | 2016 | 434 | 0.180 |
Why?
|
| Gastrointestinal Motility | 1 | 2021 | 46 | 0.180 |
Why?
|
| Thyroid Gland | 1 | 2021 | 105 | 0.180 |
Why?
|
| Teleradiology | 1 | 2020 | 5 | 0.170 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 3715 | 0.170 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 54 | 0.170 |
Why?
|
| Fractures, Bone | 1 | 2022 | 185 | 0.170 |
Why?
|
| Meals | 1 | 2020 | 57 | 0.170 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1215 | 0.170 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 12 | 0.170 |
Why?
|
| Nuclear Medicine | 1 | 2020 | 8 | 0.170 |
Why?
|
| Biological Transport | 1 | 2021 | 355 | 0.170 |
Why?
|
| Hospitals, Community | 1 | 2020 | 55 | 0.170 |
Why?
|
| Workload | 1 | 2021 | 145 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 221 | 0.170 |
Why?
|
| Acetabulum | 3 | 2024 | 16 | 0.160 |
Why?
|
| Child, Preschool | 8 | 2025 | 13882 | 0.160 |
Why?
|
| Child Health Services | 1 | 2020 | 84 | 0.160 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 144 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2014 | 142 | 0.160 |
Why?
|
| Stomach | 1 | 2021 | 272 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 386 | 0.160 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 9 | 0.160 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 190 | 0.150 |
Why?
|
| Eating | 1 | 2020 | 368 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2021 | 339 | 0.150 |
Why?
|
| Pulmonary Circulation | 1 | 2018 | 121 | 0.140 |
Why?
|
| Male | 14 | 2025 | 61317 | 0.140 |
Why?
|
| Radionuclide Imaging | 3 | 2021 | 149 | 0.130 |
Why?
|
| Software | 1 | 2021 | 683 | 0.130 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 101 | 0.120 |
Why?
|
| Infant | 7 | 2025 | 12384 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 546 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 726 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1059 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 466 | 0.110 |
Why?
|
| Inflammation | 1 | 2021 | 1440 | 0.110 |
Why?
|
| Hip Joint | 2 | 2023 | 37 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2900 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 2885 | 0.100 |
Why?
|
| Helicobacter pylori | 1 | 2020 | 1320 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 1263 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 539 | 0.080 |
Why?
|
| Esophagus | 2 | 2021 | 214 | 0.080 |
Why?
|
| Epilepsy | 1 | 2017 | 873 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 2043 | 0.070 |
Why?
|
| Adult | 6 | 2023 | 29554 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2023 | 691 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1143 | 0.070 |
Why?
|
| Lung | 1 | 2014 | 1496 | 0.070 |
Why?
|
| Necrosis | 1 | 2024 | 207 | 0.050 |
Why?
|
| Osteotomy | 1 | 2023 | 38 | 0.050 |
Why?
|
| Short Bowel Syndrome | 1 | 2024 | 65 | 0.050 |
Why?
|
| Arthroscopy | 1 | 2023 | 37 | 0.050 |
Why?
|
| Image Enhancement | 2 | 2014 | 163 | 0.050 |
Why?
|
| Young Adult | 3 | 2023 | 9023 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2023 | 135 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2023 | 260 | 0.050 |
Why?
|
| Nausea | 1 | 2022 | 86 | 0.050 |
Why?
|
| Enema | 1 | 2022 | 37 | 0.050 |
Why?
|
| Vomiting | 1 | 2022 | 104 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8163 | 0.050 |
Why?
|
| Biomarkers, Tumor | 2 | 2023 | 1492 | 0.050 |
Why?
|
| Constipation | 1 | 2022 | 114 | 0.050 |
Why?
|
| Radioisotopes | 1 | 2021 | 39 | 0.050 |
Why?
|
| Bronchi | 1 | 2021 | 97 | 0.050 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 50 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2021 | 100 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12364 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 234 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 759 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 17 | 0.040 |
Why?
|
| Triage | 1 | 2021 | 135 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 53 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1326 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 576 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2022 | 308 | 0.040 |
Why?
|
| Iopamidol | 1 | 2018 | 5 | 0.040 |
Why?
|
| Iohexol | 1 | 2018 | 21 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 194 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 41 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1873 | 0.040 |
Why?
|
| Length of Stay | 1 | 2024 | 1305 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 882 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 2446 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 199 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2021 | 541 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1287 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 816 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 49 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 1695 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 227 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 604 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 47 | 0.030 |
Why?
|
| Tyrosine | 1 | 2014 | 154 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 429 | 0.030 |
Why?
|
| Indoles | 1 | 2014 | 188 | 0.030 |
Why?
|
| Pyrroles | 1 | 2014 | 182 | 0.030 |
Why?
|
| Forecasting | 1 | 2014 | 352 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 1936 | 0.020 |
Why?
|
| Algorithms | 1 | 2018 | 1625 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3561 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 5845 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3068 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 26884 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17645 | 0.020 |
Why?
|
| United States | 1 | 2020 | 10866 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 2996 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 34235 | 0.010 |
Why?
|